ANTICANCER POTENTIAL OF PLUMBAGO ZEYLANICA LINN. AND ITS ISOLATED CONSTITUENT PLUMBAGIN: A REVIEW

被引：6

作者：

Kapare, H. S. ^{[1
]}

Metkar, S. R. ^{[1
]}

Shirolkar, S., V ^{[1
]}

机构：

[1] Dr DY Patil Inst Pharmaceut Sci & Res, Dr DY Patil Unitech Soc, Pune 411018, Maharashtra, India

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2020年 / 11卷 / 10期

关键词：

Plumbagin; Plumbago zeylanica; Cytotoxicity; Anticancer; BREAST-CANCER CELLS; CYCLE ARREST; A549; CELLS; IN-VITRO; SUPPRESSES; APOPTOSIS; 5-HYDROXY-2-METHYL-1,4-NAPHTHOQUINONE; PATHWAY; CYTOTOXICITY; FORMULATION;

D O I：

10.13040/IJPSR.0975-8232.11(10).4859-65

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Varieties of natural products have been proved as a rich source of phytoconstituents which are reported for a wide range of therapeutic potential. Plumbago zeylanica L. Is one of the herbs which are traditionally used for its therapeutic value. It is reported for several bioactive chemical constituents like naphthoquinones, flavonoids, alkaloids, glycosides, steroids, tri-terpenoids, tannins, fixed oils, fats, proteins, etc. in its chemical composition. Plumbagin is one of the most bioactive compounds of Plumbago zeylanica L., which is reported for a wide range of pharmacological activities such as anti-cancer, anti-diabetic, anti-malarial, anti-microbial, etc. It is a naphthoquinone derived yellow crystalline phytochemical constituent which is well proven for cytotoxicity against various cancer cell lines both in-vitro and in-vivo. This study is aimed to review and highlight the anticancer potential of plumbagin, formulation development approaches, and issues in the dosage form design of Plumbago zeylanica L. and its isolated constituent plumbagin.

引用

页码：4859 / 4865

页数：7

共 43 条

[1] Screening of some Indian medicinal plants for their antimicrobial properties [J].

Ahmad, I ;

Mehmood, Z ;

Mohammad, F .

JOURNAL OF ETHNOPHARMACOLOGY, 1998, 62 (02) :183-193

[2] Improved pharmaceutical properties of surface modified bioactive plumbagin crystals [J].

Bothiraja, C. ;

Pawar, Atmaram P. ;

Mali, Ashwin J. ;

Shaikh, Karimunnisa S. .

INTERNATIONAL JOURNAL OF SURFACE SCIENCE AND ENGINEERING, 2013, 7 (02) :181-195

[3]

Bothiraja C, 2013, THER DELIV, V4, P1247, DOI [10.4155/tde.13.92, 10.4155/TDE.13.92]

[4] Novel solvent-free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin [J].

Bothiraja, Chellampillai ;

Pawar, Atmaram P. ;

Dama, Ganesh Y. ;

Joshi, Prajakta P. ;

Shaikh, Karimunnisa S. .

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2012, 66 (01) :35-42

[5] Synthesis, characterization and preliminary cytotoxicity evaluation of five Lanthanide(III)-Plumbagin complexes [J].

Chen, Zhen-Feng ;

Tan, Ming-Xiong ;

Liu, Yan-Cheng ;

Peng, Yan ;

Wang, Hong-Hong ;

Liu, Hua-Gang ;

Liang, Hong .

JOURNAL OF INORGANIC BIOCHEMISTRY, 2011, 105 (03) :426-434

[6] EMERGING MECHANISMS AND POTENTIAL ANTIDEPRESSANT ACTION OF MEDICINAL PLANTS [J].

Gupta, Jitendra ;

Gupta, Reena ;

Varshney, Krishna Kumar .

INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (01) :1-13

[7]

Hiradeve S., 2010, International Journal of Biomedical Research, V1, P1, DOI DOI 10.7439/IJBR.V1I2.52

[8] Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo [J].

Hsu, Ya-Ling ;

Cho, Chien-Yu ;

Kuo, Po-Lin ;

Huang, Yu-Ting ;

Lin, Chun-Ching .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02) :484-494

[9]

Hu Xue-ying, 2011, Zhonghua Zhong Liu Za Zhi, V33, P345

[10] Cytotoxic action of juglone and plumbagin: A mechanistic study using HaCaT keratinocytes [J].

Inbaraj, JJ ;

Chignell, CF .

CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :55-62

← 1 2 3 4 5 →